04:47 PM EDT, 06/28/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on June 26, 2024, sold 7,200 shares in United Therapeutics ( UTHR ) for $2,285,941. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 647,195 shares of the company, with 130 shares held directly and 647,065 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1082554/000141588924018436/xslF345X03/form4-06282024_040631.xml